Brazil vs Jamaica: Cause of death, by non-communicable diseases, ages 15-59, male
Brazil
36.3%
in 2021
Jamaica
36.0%
in 2021
Brazil rank
153rd
Jamaica rank
154th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Brazil
- Jamaica
How they compare
Brazil currently reports 36.3% against 36.0% in Jamaica, a difference of 0.3%.
Across all 6 years both countries report, Brazil has been ahead every year.
Brazil ranks 153rd and Jamaica ranks 154th of 185 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Jamaica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.1% | 36.3% | 13.8% | Brazil |
| 2010s | 49.8% | 40.9% | 8.8% | Brazil |
| 2020s | 40.5% | 38.4% | 2.0% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Brazil or Jamaica?
- Brazil, at 36.3% against 36.0% in Jamaica as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Brazil and Jamaica?
- 0.3%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Jamaica?
- 6 years are reported by both, from 2000 to 2021.
- How do Brazil and Jamaica rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Brazil ranks 153rd and Jamaica ranks 154th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.